[
{
	"jumpto":"ENAS5567_4.3.1.0",
	"name":"A1C and CVD outcomes [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_2.3.0.0",
	"name":"A1C and mean glucose [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_4.2.0.0",
	"name":"A1C and microvascular complications, ACCORD, ADVANCE, and VADT [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_2.4.0.0",
	"name":"A1C differences, children [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_2.4.0.0",
	"name":"A1C differences, ethnic populations [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_4.1.0.0",
	"name":"A1C goals, overview [Glycemic Targets]"
},
{
	"jumpto":"ENAS5575_3.4.0.0",
	"name":"A1C in pregnancy [DM in Preg.]"
},
{
	"jumpto":"ENAS5567_2.2.0.0",
	"name":"A1C limitations [Glycemic Targets]"
},
{
	"jumpto":"interactive_0001690",
	"name":"A1C target individualization [tool]"
},
{
	"jumpto":"ENAS5567_2.1.0.0",
	"name":"A1C testing, recommendations [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_4.2.0.0",
	"name":"ACCORD, ADVANCE, and VADT [Glycemic Targets]"
},
{
	"jumpto":"ENAS5565_4.4.0.0",
	"name":"ACCORD trial [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_10.0.0.0",
	"name":"Acute care setting, transition [Hospital Care]"
},
{
	"jumpto":"ENAS5572_1.6.0.0",
	"name":"Acute kidney injury [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5569_6.2.0.0",
	"name":"Adverse effects [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5577_2.2.0.0",
	"name":"Advocacy position statements [Diab. Adv.]"
},
{
	"jumpto":"ENAS5569_3.2.0.0",
	"name":"AHEAD trial [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5572_1.3.0.0",
	"name":"Albuminuria, assessment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_3.10.0.0",
	"name":"Alcohol [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5576_5.2.1.0",
	"name":"Antihyperglycemic agents in hosp. pts., insulin therapy [Diab. Care]"
},
{
	"jumpto":"ENAS5576_5.3.0.0",
	"name":"Antihyperglycemic agents in hosp. pts., noninsulin therapies [Diab. Care]"
},
{
	"jumpto":"ENAS5576_5.1.0.0",
	"name":"Antihyperglycemic agents in hosp. pts., recommendations [Diab. Care]"
},
{
	"jumpto":"ENAS5571_5.5.0.0",
	"name":"Antihyperglycemic therapies and cardiovascular outcomes [CVD & Risk Mgmt]"
},
{
	"jumpto":"interactive_0001689",
	"name":"Antihyperglycemic therapy in T2DM [tool]"
},
{
	"jumpto":"ENAS5569_4.2.0.0",
	"name":"Antihyperglycemic therapy [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5571_4.1.0.0",
	"name":"Antiplatelet agents, recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5565_4.13.2.0",
	"name":"Anxiety disorder [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5567_4.4.0.0",
	"name":"Approach to individualization of glycemic targets [Glycemic Targets]"
},
{
	"jumpto":"ENAS5569_4.4.0.0",
	"name":"Approved weight loss medications [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5571_4.5.0.0",
	"name":"Aspirin dosing [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_4.4.0.0",
	"name":"Aspirin use in people <50 years of age [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5569_4.5.0.0",
	"name":"Assessing efficacy and safety [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5565_4.1.0.0",
	"name":"Assessment of comorbidities [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5567_1.0.0.0",
	"name":"Assessment of glycemic control [Glycemic Targets]"
},
{
	"jumpto":"ENAS5569_2.0.0.0",
	"name":"Assessment [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.8.3.0",
	"name":"Autoimmune conditions, celiac disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.8.1.0",
	"name":"Autoimmune conditions, recommendations [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.8.2.0",
	"name":"Autoimmune conditions, thyroid Disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5565_4.2.0.0",
	"name":"Autoimmune diseases [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_5.2.2.0",
	"name":"Basal insulin"
},
{
	"jumpto":"ENAS5570_4.5.2.0",
	"name":"Basal insulin [Glycemic Tx]"
},
{
	"jumpto":"ENAS5576_4.1.0.0",
	"name":"Bedside blood glucose monitoring, indications [Diab. Care]"
},
{
	"jumpto":"ENAS5576_4.2.0.0",
	"name":"Bedside blood glucose monitoring, Point-of-care meters [Diab. Care]"
},
{
	"jumpto":"ENAS5571_2.4.2.5",
	"name":"Bedtime dosing [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5569_3.1.0.0",
	"name":"Behavioral therapy [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5572_3.2.5.0",
	"name":"Bladder dysfunction [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5574_1.7.0.0",
	"name":"Blood glucose and A1C goals [Child. & Adol.]"
},
{
	"jumpto":"ENAS5572_1.8.5.0",
	"name":"Blood pressure [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5570_4.5.4.0",
	"name":"Bolus insulin [Glycemic Tx]"
},
{
	"jumpto":"ENAS5575_7.1.0.0",
	"name":"Breastfeeding [DM in Preg.]"
},
{
	"jumpto":"ENAS5565_4.3.0.0",
	"name":"Cancer [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Carbamazepine [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_3.5.0.0",
	"name":"Carbohydrates [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5572_3.2.3.0",
	"name":"Cardiac autonomic neuropathy, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5571_5.2.0.0",
	"name":"Cardiac testing [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5572_1.8.5.0",
	"name":"Cardiovascular disease [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5570_4.4.0.0",
	"name":"Cardiovascular outcomes Trials [Glycemic Tx]"
},
{
	"jumpto":"ENAS5574_1.9.2.0",
	"name":"Cardiovascular risk, dyslipidemia [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.9.1.0",
	"name":"Cardiovascular risk, hypertension [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.9.3.0",
	"name":"Cardiovascular risk, smoking [Child. & Adol.]"
},
{
	"jumpto":"ENAS5562_2.1.0.0",
	"name":"Care delivery systems [Population Health]"
},
{
	"jumpto":"ENAS5574_1.8.3.0",
	"name":"Celiac disease, recommendations [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.8.3.0",
	"name":"Celiac disease, screening [Child. & Adol.]"
},
{
	"jumpto":"ENAS5576_4.3.0.0",
	"name":"CGM [Diab. Care]"
},
{
	"jumpto":"ENAS5567_1.0.0.0",
	"name":"CGM [Glycemic Targets]"
},
{
	"jumpto":"ENAS5577_2.3.0.0",
	"name":"Child care setting, care of young children [Diab. Adv.]"
},
{
	"jumpto":"ENAS5562_2.2.0.0",
	"name":"Chronic care model [Population Health]"
},
{
	"jumpto":"ENAS5572_1.3.0.0",
	"name":"Chronic kidney disease, albuminuria assessment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.4.0.0",
	"name":"Chronic kidney disease, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.5.0.0",
	"name":"Chronic kidney disease, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.3.0.0",
	"name":"Chronic kidney disease, eGFR assessment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.2.0.0",
	"name":"Chronic kidney disease, epidemiology [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.8.1.0",
	"name":"Chronic kidney disease, interventions [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.8.1.0",
	"name":"Chronic kidney disease, nutrition [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.1.0.0",
	"name":"Chronic kidney disease, screening recom. [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.5.0.0",
	"name":"Chronic kidney disease, stages [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.7.0.0",
	"name":"Chronic kidney disease, surveillance [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.1.0.0",
	"name":"Chronic kidney disease, treatment recom. [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.1.0.0",
	"name":"Chronic kidney disease [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.7.0.0",
	"name":"CKD, complications of [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_1.5.0.0",
	"name":"CKD stages [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5571_2.4.2.3",
	"name":"Classes of antihypertensive medications [CVD & risk mgmt]"
},
{
	"jumpto":"ENAS5565_4.4.0.0",
	"name":"Cognitive impairment/dementia [Eval. of Comorbidities]"
},
{
	"jumpto":"interactive_0001688",
	"name":"Combination injectable therapy [tool]"
},
{
	"jumpto":"ENAS5571_3.4.1.0",
	"name":"Combination therapy for LDL cholesterol lowering [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5570_4.3.0.0",
	"name":"Combination therapy [Glycemic Tx]"
},
{
	"jumpto":"ENAS5562_3.5.0.0",
	"name":"Community support [Population Health]"
},
{
	"jumpto":"ENAS5565_4.1.0.0",
	"name":"Comorbidities evaluation, assessment [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5570_4.5.6.0",
	"name":"Concentrated insulin products [Glycemic Tx]"
},
{
	"jumpto":"ENAS5569_4.3.0.0",
	"name":"Concomitant medications [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5561_1.2.0.0",
	"name":"Consensus reports"
},
{
	"jumpto":"ENAS5576_2.2.0.0",
	"name":"Considerations on admission [Diab. Care]"
},
{
	"jumpto":"ENAS5576_4.3.0.0",
	"name":"Continuous glucose monitoring [Diab. Care]"
},
{
	"jumpto":"ENAS5567_1.0.0.0",
	"name":"Continuous glucose monitoring [Glycemic Targets]"
},
{
	"jumpto":"ENAS5576_8.0.0.0",
	"name":"Continuous subcutaneous insulin infusion [Diab. Care]"
},
{
	"jumpto":"ENAS5575_7.5.0.0",
	"name":"Contraception [DM in Preg.]"
},
{
	"jumpto":"ENAS5571_5.1.0.0",
	"name":"Coronary heart disease, screening recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_5.1.0.0",
	"name":"Coronary heart disease, treatment recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5577_2.6.0.0",
	"name":"Correctional institutions, diabetes mgmt. [Diab. Adv.]"
},
{
	"jumpto":"ENAS5576_5.2.1.0",
	"name":"Critical care setting [Diab. Care]"
},
{
	"jumpto":"ENAS5576_8.0.0.0",
	"name":"CSII [Diab. Care]"
},
{
	"jumpto":"ENAS5564_4.0.0.0",
	"name":"CVD, prevention [T2DM Prev.]"
},
{
	"jumpto":"ENAS5567_4.3.1.0",
	"name":"CVD and type 1 diabetes [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_4.3.2.0",
	"name":"CVD and type 2 diabetes [Glycemic Targets]"
},
{
	"jumpto":"ENAS5572_1.8.5.0",
	"name":"CVD [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_3.3.0.0",
	"name":"DASH diet [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5572_1.8.2.0",
	"name":"DCCT [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5565_4.13.3.0",
	"name":"Depression [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5575_1.0.0.0",
	"name":"Diabetes, pregnancy"
},
{
	"jumpto":"ENAS5564_5.0.0.0",
	"name":"Diabetes, self-management education & support [T2DM Prev.]"
},
{
	"jumpto":"ENAS5577_1.0.0.0",
	"name":"Diabetes advocacy, introduction"
},
{
	"jumpto":"ENAS5577_2.4.0.0",
	"name":"Diabetes and driving [Diab. Adv.]"
},
{
	"jumpto":"ENAS5577_2.5.0.0",
	"name":"Diabetes and employment [Diab. Adv.]"
},
{
	"jumpto":"ENAS5562_1.0.0.0",
	"name":"Diabetes and population health, recommendations"
},
{
	"jumpto":"ENAS5576_1.0.0.0",
	"name":"Diabetes care, introduction"
},
{
	"jumpto":"ENAS5577_2.2.0.0",
	"name":"Diabetes care, school setting [Diab. Adv.]"
},
{
	"jumpto":"ENAS5576_2.4.0.0",
	"name":"Diabetes care providers [Diab. Care]"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication cardiac function esting"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication cardiovascular disease"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication dyslipidemia"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication nonalcoholic fatty liver disease"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication obstructive sleep apnea"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complication polycystic ovary syndrome"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complications nephropathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complications neuropathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.5.0.0",
	"name":"Diabetes complications retinopathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5572_1.8.2.0",
	"name":"Diabetes Control and Complications Trial [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_6.4.2.0",
	"name":"Diabetes distress, recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5577_2.6.0.0",
	"name":"Diabetes mgmt. in correctional inst. [Diab. Adv.]"
},
{
	"jumpto":"ENAS5566_3.9.0.0",
	"name":"Diabetes Prevention Program Outcomes Study [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5564_2.2.0.0",
	"name":"Diabetes Prevention Program [T2DM Prev.]"
},
{
	"jumpto":"ENAS5562_3.3.0.0",
	"name":"Diabetes self-management education and support [Population Health]"
},
{
	"jumpto":"ENAS5574_1.2.0.0",
	"name":"Diabetes Self-mgmt. education & support [Child. & Adol.]"
},
{
	"jumpto":"ENAS5571_3.7.0.0",
	"name":"Diabetes with statin use [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5572_3.2.2.0",
	"name":"Diabetic autonomic neuropathy, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5576_9.4.0.0",
	"name":"Diabetic ketoacidosis [Hospital Care]"
},
{
	"jumpto":"ENAS5574_1.10.1.0",
	"name":"Diabetic kidney disease, recommendations [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.10.1.0",
	"name":"Diabetic kidney disease, screening [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.10.1.0",
	"name":"Diabetic kidney disease, treatment [Child. & Adol.]"
},
{
	"jumpto":"ENAS5572_3.2.1.0",
	"name":"Diabetic peripheral neuropathy, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_2.1.0.0",
	"name":"Diabetic retinopathy, recommendations [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_2.2.0.0",
	"name":"Diabetic retinopathy, screening [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_2.3.0.0",
	"name":"Diabetic retinopathy, treatment [Microvasc. Compli.]"
},
{
	"jumpto":"interactive_0001691",
	"name":"Diagnosis of diabetes and prediabetes [tool]"
},
{
	"jumpto":"ENAS5569_3.1.0.0",
	"name":"Diet [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5565_4.13.4.0",
	"name":"Disordered eating behavior [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5564_5.0.0.0",
	"name":"DM self-management education & support [T2DM Prev.]"
},
{
	"jumpto":"ENAS5572_3.2.1.0",
	"name":"DPN, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5564_2.2.0.0",
	"name":"DPP [T2DM Prev.]"
},
{
	"jumpto":"interactive_0001693",
	"name":"Drug-specific & pt. factors in T2DM Tx [tool]"
},
{
	"jumpto":"ENAS5566_2.1.0.0",
	"name":"DSMES, recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5562_3.3.0.0",
	"name":"DSMES [Population Health]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Duloxetine [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5574_1.9.2.0",
	"name":"Dyslipidemia, pathophysiology [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.9.2.0",
	"name":"Dyslipidemia, recommendations [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.9.2.0",
	"name":"Dyslipidemia, treatment [Child. & Adol.]"
},
{
	"jumpto":"ENAS5566_5.2.0.0",
	"name":"E-cigarettes [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5572_1.3.0.0",
	"name":"eGFR assessment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5573_8.0.0.0",
	"name":"End-of-life care in older adults, recommendations"
},
{
	"jumpto":"ENAS5576_9.1.0.0",
	"name":"Enteral/parenteral feedings, insulin dosing [Diab. Care]"
},
{
	"jumpto":"ENAS5576_9.1.0.0",
	"name":"Enteral feedings [Diab. Care]"
},
{
	"jumpto":"ENAS5572_3.3.5.0",
	"name":"Erectile dysfunction [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5561_1.3.0.0",
	"name":"Evidence-grading system ADA"
},
{
	"jumpto":"ENAS5566_4.8.3.0",
	"name":"Exercise and autonomic neuropathy [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.3.0.0",
	"name":"Exercise and children [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.8.4.0",
	"name":"Exercise and diabetic kidney disease [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.8.2.0",
	"name":"Exercise and peripheral neuropathy [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.8.1.0",
	"name":"Exercise and retinopathy [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.8.1.0",
	"name":"Exercise in complications of DM [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_3.7.0.0",
	"name":"Fats [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5565_4.5.0.0",
	"name":"Fatty liver disease [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5562_3.2.0.0",
	"name":"Food insecurity [Population Health]"
},
{
	"jumpto":"ENAS5572_4.4.0.0",
	"name":"Foot care, patient education [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_4.1.0.0",
	"name":"Foot care, recommendations [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_4.5.0.0",
	"name":"Foot care, treatment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5565_4.7.0.0",
	"name":"Fractures [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Gabapentin [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.2.4.0",
	"name":"Gastrointestinal neuropathies, diagnosis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.3.4.0",
	"name":"Gastroparesis [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.2.5.0",
	"name":"Genitourinary disturbances [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5575_7.3.0.0",
	"name":"Gestational diabetes mellitus & T2D [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.2.1.0",
	"name":"Gestational diabetes mellitus, initial testing [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.2.0.0",
	"name":"Gestational diabetes mellitus, lifestyle management [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.3.0.0",
	"name":"Gestational diabetes mellitus, medical nutrition therapy [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.1.0.0",
	"name":"Gestational diabetes mellitus, mgmt. [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.2.2.0",
	"name":"Gestational diabetes mellitus, postpartum follow-up [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_1.0.0.0",
	"name":"Gestational diabetes mellitus [DM in Preg.]"
},
{
	"jumpto":"ENAS5567_5.2.2.0",
	"name":"Glucagon [Glycemic Targets]"
},
{
	"jumpto":"ENAS5576_9.2.0.0",
	"name":"Glucocorticoid therapy [Diab. Care]"
},
{
	"jumpto":"ENAS5572_1.8.4.0",
	"name":"Glucose-lowering medications, in Chronic kidney disease"
},
{
	"jumpto":"ENAS5569_4.1.0.0",
	"name":"Glucose-lowering medications [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5576_3.2.0.0",
	"name":"Glucose abnormalities, definition [Diab. Care]"
},
{
	"jumpto":"ENAS5567_3.0.0.0",
	"name":"Glucose Assessment [Glycemic Targets]"
},
{
	"jumpto":"ENAS5575_3.3.0.0",
	"name":"Glucose monitoring [DM in Preg.]"
},
{
	"jumpto":"ENAS5572_1.8.2.0",
	"name":"Glycemia, Chronic kidney disease in [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5576_3.3.0.0",
	"name":"Glycemic control, moderate versus tight [Diab. Care]"
},
{
	"jumpto":"ENAS5574_1.7.0.0",
	"name":"Glycemic control [Child. & Adol.]"
},
{
	"jumpto":"ENAS5567_4.4.0.0",
	"name":"Glycemic recommendations for many nonpregnant adults with diabetes [Glycemic Targets]"
},
{
	"jumpto":"ENAS5575_3.4.0.0",
	"name":"Glycemic targets, A1C in pregnancy [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_3.3.0.0",
	"name":"Glycemic targets, glucose monitoring [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_3.2.0.0",
	"name":"Glycemic targets, insulin physiology [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_3.1.0.0",
	"name":"Glycemic targets, recommendations [DM in Preg.]"
},
{
	"jumpto":"ENAS5576_3.1.0.0",
	"name":"Glycemic targets in hospitalized patients, recommendations [Diab. Care]"
},
{
	"jumpto":"ENAS5565_4.8.0.0",
	"name":"Hearing impairment [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5565_3.0.0.0",
	"name":"Hepatitis B"
},
{
	"jumpto":"ENAS5565_4.5.0.0",
	"name":"Hepatocellular carcinoma [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5571_3.3.2.0",
	"name":"High-intensity and moderate-intensity statin therapy [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5565_4.9.0.0",
	"name":"HIV [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_2.2.0.0",
	"name":"Hospital care delivery standards, admission [Diab. Care]"
},
{
	"jumpto":"ENAS5576_2.4.0.0",
	"name":"Hospital care delivery standards, diabetes care providers [Diab. Care]"
},
{
	"jumpto":"ENAS5576_2.3.0.0",
	"name":"Hospital care delivery standards, physician order entry [Diab. Care]"
},
{
	"jumpto":"ENAS5576_2.5.0.0",
	"name":"Hospital care delivery standards, quality assurance standards [Diab. Care]"
},
{
	"jumpto":"ENAS5576_2.1.0.0",
	"name":"Hospital care delivery standards, recommendations [Diab. Care]"
},
{
	"jumpto":"ENAS5565_4.4.0.0",
	"name":"Hyperglycemia/hypoglycemia and Cognitive impairment [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5571_2.4.3.0",
	"name":"Hyperkalemia and AKI [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5576_9.4.0.0",
	"name":"Hyperosmolar hyperglycemic state [Hospital Care]"
},
{
	"jumpto":"ENAS5574_1.9.1.0",
	"name":"Hypertension, screening [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.9.1.0",
	"name":"Hypertension, treatment [Child. & Adol.]"
},
{
	"jumpto":"ENAS5571_2.1.0.0",
	"name":"Hypertension/blood pressure control [CVD & risk mgmt]"
},
{
	"jumpto":"interactive_0001792",
	"name":"Hypertension treatment [tool]"
},
{
	"jumpto":"ENAS5574_1.9.1.0",
	"name":"Hypertension [Child. & Adol.]"
},
{
	"jumpto":"ENAS5572_1.8.5.0",
	"name":"Hypertension [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5576_6.3.0.0",
	"name":"Hypoglycemia, predictors [Diab. Care]"
},
{
	"jumpto":"ENAS5576_6.4.0.0",
	"name":"Hypoglycemia, prevention [Diab. Care]"
},
{
	"jumpto":"ENAS5576_6.1.0.0",
	"name":"Hypoglycemia, recommendations [Diab. Care]"
},
{
	"jumpto":"ENAS5567_5.1.0.0",
	"name":"Hypoglycemia, recommendations [Glycemic Targets]"
},
{
	"jumpto":"ENAS5576_6.2.0.0",
	"name":"Hypoglycemia, triggering events [Diab. Care]"
},
{
	"jumpto":"ENAS5566_4.7.0.0",
	"name":"Hypoglycemia and physical activity [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5573_3.0.0.0",
	"name":"Hypoglycemia in older adults, recommendations"
},
{
	"jumpto":"ENAS5567_5.3.0.0",
	"name":"Hypoglycemia prevention [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_5.2.1.0",
	"name":"Hypoglycemia treatment, overview [Glycemic Targets]"
},
{
	"jumpto":"ENAS5576_11.1.0.0",
	"name":"Hypoglycemic admissions, older adults [Hospital Care]"
},
{
	"jumpto":"ENAS5565_4.10.0.0",
	"name":"Hypogonadism [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_6.2.0.0",
	"name":"Iatrogenic hypoglycemia [Diab. Care]"
},
{
	"jumpto":"ENAS5565_3.0.0.0",
	"name":"Immunizations"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Incretin-based therapies, in older adults"
},
{
	"jumpto":"ENAS5571_4.6.0.0",
	"name":"Indications for P2Y12 use [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_2.3.4.0",
	"name":"Individualization of treatment targets [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_2.4.2.2",
	"name":"Initial number of antihypertensive medications [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5570_4.2.0.0",
	"name":"Initial therapy [Glycemic Tx]"
},
{
	"jumpto":"ENAS5571_3.3.2.0",
	"name":"Initiating statin therapy based on risk [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5575_3.2.0.0",
	"name":"Insulin physiology [DM in Preg.]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Insulin secretagogues, in older adults"
},
{
	"jumpto":"ENAS5576_5.2.1.0",
	"name":"Insulin therapy, critical care setting [Diab. Care]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Insulin therapy, in older adults"
},
{
	"jumpto":"ENAS5576_5.2.2.0",
	"name":"Insulin therapy, noncritical care setting [Diab. Care]"
},
{
	"jumpto":"ENAS5576_5.2.4.0",
	"name":"Insulin therapy, transitioning IV to SQ insulin [Diab. Care]"
},
{
	"jumpto":"ENAS5576_5.2.3.0",
	"name":"Insulin therapy, type 1 diabetes [Diab. Care]"
},
{
	"jumpto":"ENAS5570_2.2.0.0",
	"name":"Insulin therapy [Glycemic Tx]"
},
{
	"jumpto":"ENAS5570_4.5.1.0",
	"name":"Insulin therapy [Glycemic Tx]"
},
{
	"jumpto":"ENAS5575_5.1.0.0",
	"name":"Insulin use [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.4.4.0",
	"name":"Insulin [DM in Preg.]"
},
{
	"jumpto":"ENAS5567_1.0.0.0",
	"name":"Intensive insulin regimens [Glycemic Targets]"
},
{
	"jumpto":"ENAS5567_6.0.0.0",
	"name":"Intercurrent illness [Glycemic Targets]"
},
{
	"jumpto":"ENAS5576_5.2.1.0",
	"name":"Intravenous insulin infusion [Diab. Care]"
},
{
	"jumpto":"ENAS5571_1.0.0.0",
	"name":"Introduction [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5565_4.6.0.0",
	"name":"Islet autotransplantation [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5575_7.1.0.0",
	"name":"Lactation [DM in Preg.]"
},
{
	"jumpto":"ENAS5562_3.4.0.0",
	"name":"Language barriers [Population Health]"
},
{
	"jumpto":"ENAS5571_5.4.0.0",
	"name":"Lifestyle and pharmacologic interventions [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5564_2.6.0.0",
	"name":"Lifestyle interventions, cost-effectiveness [T2DM Prev.]"
},
{
	"jumpto":"ENAS5564_2.3.0.0",
	"name":"Lifestyle interventions, nutrition [T2DM Prev.]"
},
{
	"jumpto":"ENAS5564_2.4.0.0",
	"name":"Lifestyle interventions, physical activity [T2DM Prev.]"
},
{
	"jumpto":"ENAS5564_2.5.0.0",
	"name":"Lifestyle interventions, technology assistance [T2DM Prev.]"
},
{
	"jumpto":"ENAS5569_3.3.0.0",
	"name":"Lifestyle interventions [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5564_2.2.0.0",
	"name":"Lifestyle interventions [T2DM Prev.]"
},
{
	"jumpto":"ENAS5571_3.1.0.0",
	"name":"Lifestyle intervention [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5566_1.0.0.0",
	"name":"Lifestyle management"
},
{
	"jumpto":"ENAS5575_4.2.0.0",
	"name":"Lifestyle management [DM in Preg.]"
},
{
	"jumpto":"ENAS5573_5.0.0.0",
	"name":"Lifestyle Management [Older Adults]"
},
{
	"jumpto":"ENAS5571_3.1.0.0",
	"name":"Lipid management [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.2.0.0",
	"name":"lipid panel [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5569_3.2.0.0",
	"name":"Look AHEAD trial [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5572_4.2.0.0",
	"name":"LOPS, evaluation [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_3.3.0.0",
	"name":"Macronutrient distribution [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_2.4.2.0",
	"name":"Management of new-onset diabetes in overweight youth"
},
{
	"jumpto":"ENAS5566_3.3.0.0",
	"name":"Meal planning [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5567_2.3.0.0",
	"name":"Mean glucose levels for specified A1C levels [Glycemic Targets]"
},
{
	"jumpto":"ENAS5565_1.0.0.0",
	"name":"Medical evaluation [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_7.0.0.0",
	"name":"Medical nutrition therapy, hospital [Diab. Care]"
},
{
	"jumpto":"ENAS5575_4.3.0.0",
	"name":"Medical nutrition therapy [DM in Preg.]"
},
{
	"jumpto":"ENAS5565_2.0.0.0",
	"name":"Medical nutrition therapy [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5566_2.4.0.0",
	"name":"Medicare [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5576_10.0.0.0",
	"name":"Medication reconciliation [Hospital Care]"
},
{
	"jumpto":"ENAS5569_4.4.0.0",
	"name":"Medications, long-term treatment [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5569_4.4.0.0",
	"name":"Medications, short-term treatment [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5565_4.4.0.0",
	"name":"Mediterranean diet [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5566_6.5.0.0",
	"name":"Mental health specialist [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5571_2.3.3.0",
	"name":"Meta-analyses of trials [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5574_2.4.3.0",
	"name":"Metabolic surgery"
},
{
	"jumpto":"ENAS5569_6.2.0.0",
	"name":"Metabolic surgery, adverse effects [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5569_6.1.0.0",
	"name":"Metabolic surgery, recommendations [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Metformin, in older adults"
},
{
	"jumpto":"ENAS5575_4.4.3.0",
	"name":"Metformin [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.1.0.0",
	"name":"Mgmt., gestational diabetes mellitus [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_5.1.0.0",
	"name":"Mgmt., preexisting T1D & T2D [DM in Preg.]"
},
{
	"jumpto":"ENAS5566_3.9.0.0",
	"name":"Micronutrients and supplements [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.10.1.0",
	"name":"Microvascular complications, diabetic kidney disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.10.3.0",
	"name":"Microvascular complications, neuropathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.10.2.0",
	"name":"Microvascular complications, retinopathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5566_3.1.0.0",
	"name":"MNT recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5565_2.0.0.0",
	"name":"MNT [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_3.3.0.0",
	"name":"Moderate versus tight glycemic control [Diab. Care]"
},
{
	"jumpto":"ENAS5566_3.5.0.0",
	"name":"Modified plate method [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5571_2.4.2.4",
	"name":"Multiple-drug therapy [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5562_3.3.0.0",
	"name":"National diabetes education program [Population Health]"
},
{
	"jumpto":"ENAS5573_2.0.0.0",
	"name":"Neurocognitive function in older adults, recommendations"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Neuropathic pain, treatment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.3.1.0",
	"name":"Neuropathy, glycemic control [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.1.0.0",
	"name":"Neuropathy, recommendations [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5572_3.3.1.0",
	"name":"Neuropathy, treatment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5574_1.10.3.0",
	"name":"Neuropathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5565_4.5.0.0",
	"name":"Nonalcoholic chronic liver disease [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_5.2.2.0",
	"name":"Noncritical care setting [Diab. Care]"
},
{
	"jumpto":"ENAS5576_5.3.0.0",
	"name":"Noninsulin therapies [Diab. Care]"
},
{
	"jumpto":"ENAS5574_1.3.0.0",
	"name":"Nutrition therapy"
},
{
	"jumpto":"ENAS5566_3.2.0.0",
	"name":"Nutrition therapy, goals for adults with DM [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_3.1.0.0",
	"name":"Nutrition therapy [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5564_2.3.0.0",
	"name":"Nutrition [T2DM Prev.]"
},
{
	"jumpto":"ENAS5569_1.0.0.0",
	"name":"Obesity management, introduction"
},
{
	"jumpto":"ENAS5565_4.11.0.0",
	"name":"Obstructive sleep apnea [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_11.1.0.0",
	"name":"Older adults, hypoglycemic admissions [Hospital Care]"
},
{
	"jumpto":"ENAS5573_1.0.0.0",
	"name":"Older adults, recommendations"
},
{
	"jumpto":"ENAS5573_4.1.0.0",
	"name":"Older adults, treatment recommendations"
},
{
	"jumpto":"ENAS5571_3.2.0.0",
	"name":"Ongoing therapy and monitoring with"
},
{
	"jumpto":"ENAS5575_4.1.0.0",
	"name":"Oral glucose tolerance test [DM in Preg.]"
},
{
	"jumpto":"ENAS5572_3.3.3.0",
	"name":"Orthostatic hypotension, treatment [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5571_3.6.1.0",
	"name":"Other combination therapy, recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5570_1.0.0.0",
	"name":"Overview"
},
{
	"jumpto":"ENAS5571_2.1.0.0",
	"name":"Overview [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5570_4.5.1.0",
	"name":"Overview [Glycemic Tx]"
},
{
	"jumpto":"ENAS5569_2.0.0.0",
	"name":"Overweight and obesity, treatment options"
},
{
	"jumpto":"ENAS5572_4.3.0.0",
	"name":"PAD, evaluation [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5565_4.6.0.0",
	"name":"Pancreatitis [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_9.1.0.0",
	"name":"Parenteral feedings [Diab. Care]"
},
{
	"jumpto":"ENAS5565_1.0.0.0",
	"name":"Patient-centered collaborative care [Comorbidities]"
},
{
	"jumpto":"ENAS5562_2.3.0.0",
	"name":"Patient-centered medical home [Population Health]"
},
{
	"jumpto":"ENAS5574_3.0.0.0",
	"name":"Pediatric to adult care, transition [Child. & Adol.]"
},
{
	"jumpto":"ENAS5565_4.12.0.0",
	"name":"Periodontal disease [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5576_9.3.0.0",
	"name":"Perioperative care [Hospital Care]"
},
{
	"jumpto":"ENAS5570_2.1.0.0",
	"name":"Pharm. therapy for type 1 diabetes, recommendations [Glycemic Tx]"
},
{
	"jumpto":"ENAS5571_2.4.2.1",
	"name":"Pharmacologic interventions, recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5564_3.0.0.0",
	"name":"Pharmacologic interventions [T2DM Prev.]"
},
{
	"jumpto":"ENAS5575_4.4.4.0",
	"name":"Pharmacologic therapy, insulin [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.4.3.0",
	"name":"Pharmacologic therapy, metformin [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_4.4.1.0",
	"name":"Pharmacologic therapy, overview [DM in Preg.]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Pharmacologic therapy, recommendations"
},
{
	"jumpto":"ENAS5575_4.4.2.0",
	"name":"Pharmacologic therapy, sulfonylureas [DM in Preg.]"
},
{
	"jumpto":"ENAS5570_2.1.0.0",
	"name":"Pharmacologic therapy for type 1 Diabetes [Glycemic Tx]"
},
{
	"jumpto":"ENAS5570_4.1.0.0",
	"name":"Pharmacologic therapy for type 2 Diabetes, recommendations [Glycemic Tx]"
},
{
	"jumpto":"ENAS5570_4.1.0.0",
	"name":"Pharmacologic therapy for type 2 Diabetes [Glycemic Tx]"
},
{
	"jumpto":"ENAS5569_4.2.0.0",
	"name":"Pharmacotherapy, antihyperglycemic therapy [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5569_4.3.0.0",
	"name":"Pharmacotherapy, concomitant medications [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5569_4.1.0.0",
	"name":"Pharmacotherapy, recommendations [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.4.0.0",
	"name":"Physical activity, frequency and type [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.2.0.0",
	"name":"Physical activity, recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.4.0.0",
	"name":"Physical activity and exercise"
},
{
	"jumpto":"ENAS5566_4.5.0.0",
	"name":"Physical activity and glycemic control [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_4.7.0.0",
	"name":"Physical activity and hypoglycemia [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5569_3.1.0.0",
	"name":"Physical activity [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5564_2.4.0.0",
	"name":"Physical activity [T2DM Prev.]"
},
{
	"jumpto":"ENAS5576_2.3.0.0",
	"name":"Physician order entry [Diab. Care]"
},
{
	"jumpto":"ENAS5566_3.3.0.0",
	"name":"Plant-based diets [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5565_3.0.0.0",
	"name":"Pneumococcal pneumonia"
},
{
	"jumpto":"ENAS5576_4.2.0.0",
	"name":"Point-of-care meters [Diab. Care]"
},
{
	"jumpto":"ENAS5567_2.1.0.0",
	"name":"Point-of-care testing [Glycemic Targets]"
},
{
	"jumpto":"ENAS5575_7.5.0.0",
	"name":"Postpartum care, contraception [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.3.0.0",
	"name":"Postpartum care, gestational diabetes mellitus & T2D [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.1.0.0",
	"name":"Postpartum care, lactation [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.4.0.0",
	"name":"Postpartum care, preexisting type 1 and type 2 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.2.2.0",
	"name":"Postpartum follow-up [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_3.3.0.0",
	"name":"Postprandial monitoring [DM in Preg.]"
},
{
	"jumpto":"ENAS5570_2.3.0.0",
	"name":"Pramlintide [Glycemic Tx]"
},
{
	"jumpto":"ENAS5566_4.6.0.0",
	"name":"Pre-exercise evaluation [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5575_2.1.0.0",
	"name":"Preconception counseling, recommendations [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_2.2.0.0",
	"name":"Preconception testing [DM in Preg.]"
},
{
	"jumpto":"ENAS5576_6.3.0.0",
	"name":"Predictors of hypoglycemia [Diab. Care]"
},
{
	"jumpto":"ENAS5575_5.2.0.0",
	"name":"Preeclampsia and aspirin [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_5.1.0.0",
	"name":"Preexisting T1D & T2D mgmt., insulin use [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_5.2.0.0",
	"name":"Preexisting T1D & T2D mgmt., preeclampsia and aspirin [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_5.3.0.0",
	"name":"Preexisting T1D & T2D mgmt., type 1 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_5.4.0.0",
	"name":"Preexisting T1D & T2D mgmt., type 2 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5575_7.4.0.0",
	"name":"Preexisting type 1 and type 2 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Pregabalin [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5575_1.0.0.0",
	"name":"Pregnancy, diabetes"
},
{
	"jumpto":"ENAS5575_3.1.0.0",
	"name":"Pregnancy, glycemic targets [DM in Preg.]"
},
{
	"jumpto":"ENAS5571_2.3.5.0",
	"name":"Pregnancy and antihypertensive medications"
},
{
	"jumpto":"ENAS5575_6.0.0.0",
	"name":"Pregnancy and drug considerations [DM in Preg.]"
},
{
	"jumpto":"ENAS5570_4.5.5.0",
	"name":"Premixed insulin [Glycemic Tx]"
},
{
	"jumpto":"ENAS5575_3.3.0.0",
	"name":"Preprandial testing [DM in Preg.]"
},
{
	"jumpto":"ENAS5576_11.1.0.0",
	"name":"Prev. admissions & readmissions [Hospital Care]"
},
{
	"jumpto":"ENAS5576_11.1.0.0",
	"name":"Prev. hypoglycemic adm. in older adults [Hospital Care]"
},
{
	"jumpto":"ENAS5576_11.2.0.0",
	"name":"Preventing readmissions [Hospital Care]"
},
{
	"jumpto":"ENAS5564_4.0.0.0",
	"name":"Prevention of CVD [T2DM Prev.]"
},
{
	"jumpto":"ENAS5564_1.0.0.0",
	"name":"Prevention or delay of type 2 diabetes, introduction"
},
{
	"jumpto":"ENAS5571_3.3.3.2",
	"name":"Primary prevention, age <40 years and/or type 1 diabetes [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.3.3.1",
	"name":"Primary prevention, age >40 years & older (Patients w/o ASCVD) [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5561_2.0.0.0",
	"name":"Professional Practice Committee (PPC)"
},
{
	"jumpto":"ENAS5566_3.6.0.0",
	"name":"Protein [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5565_4.13.1.0",
	"name":"Psychosocial/emotional disorders [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5566_6.2.0.0",
	"name":"Psychosocial care [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_2.6.0.0",
	"name":"Psychosocial factors"
},
{
	"jumpto":"ENAS5566_6.4.2.0",
	"name":"Psychosocial issues, diabetes distress [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.6.0.0",
	"name":"Psychosocial issues, recommendations [Child. & Adol.]"
},
{
	"jumpto":"ENAS5566_6.2.0.0",
	"name":"Psychosocial issues, recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.6.0.0",
	"name":"Psychosocial issues, screening [Child. & Adol.]"
},
{
	"jumpto":"ENAS5566_6.3.0.0",
	"name":"Psychosocial issues, screening [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5576_2.5.0.0",
	"name":"Quality assurance standards [Diab. Care]"
},
{
	"jumpto":"ENAS5571_2.3.2.0",
	"name":"Randomized controlled trials of intensive versus standard BP control [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.3.2.0",
	"name":"Recommendations for statin and combination treatment in adults with diabetes [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5572_1.8.3.0",
	"name":"Renal effects of glucose-lowering medications [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5571_2.4.4.0",
	"name":"Resistant hypertension [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5574_1.10.2.0",
	"name":"Retinopathy [Child. & Adol.]"
},
{
	"jumpto":"ENAS5561_3.2.1.0",
	"name":"Revision, section 1"
},
{
	"jumpto":"ENAS5561_3.2.2.0",
	"name":"Revisions, section 2"
},
{
	"jumpto":"ENAS5561_3.2.3.0",
	"name":"Revisions, section 3"
},
{
	"jumpto":"ENAS5561_3.2.4.0",
	"name":"Revisions, section 4"
},
{
	"jumpto":"ENAS5561_3.2.5.0",
	"name":"Revisions, section 5"
},
{
	"jumpto":"ENAS5561_3.2.6.0",
	"name":"Revisions, section 6"
},
{
	"jumpto":"ENAS5561_3.2.7.0",
	"name":"Revisions, section 7"
},
{
	"jumpto":"ENAS5561_3.2.8.0",
	"name":"Revisions, section 8"
},
{
	"jumpto":"ENAS5561_3.2.9.0",
	"name":"Revisions, section 9"
},
{
	"jumpto":"ENAS5561_3.2.10.0",
	"name":"Revisions, section 10"
},
{
	"jumpto":"ENAS5561_3.2.11.0",
	"name":"Revisions, section 11"
},
{
	"jumpto":"ENAS5561_3.2.12.0",
	"name":"Revisions, section 12"
},
{
	"jumpto":"ENAS5561_3.2.13.0",
	"name":"Revisions, section 13"
},
{
	"jumpto":"ENAS5561_3.2.14.0",
	"name":"Revisions, section 14"
},
{
	"jumpto":"ENAS5561_3.2.15.0",
	"name":"Revisions, section 15"
},
{
	"jumpto":"ENAS5561_3.2.16.0",
	"name":"Revisions, section 16"
},
{
	"jumpto":"ENAS5561_3.2.1.0",
	"name":"Revisions summary"
},
{
	"jumpto":"ENAS5571_4.2.0.0",
	"name":"Risk reduction [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5574_1.5.0.0",
	"name":"School and child care [Child. & Adol.]"
},
{
	"jumpto":"ENAS5577_2.2.0.0",
	"name":"School setting [Diab. Adv.]"
},
{
	"jumpto":"ENAS5561_1.2.0.0",
	"name":"ScientiÔ¨Åc reviews"
},
{
	"jumpto":"ENAS5574_2.2.0.0",
	"name":"Screening and Diagnosis"
},
{
	"jumpto":"ENAS5571_2.2.0.0",
	"name":"Screening and diagnosis [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_5.3.0.0",
	"name":"Screening asymptomatic patients [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.3.4.0",
	"name":"Secondary preventions (patients w/ASCVD) [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5576_8.0.0.0",
	"name":"Self-management, hospital [Diab. Care]"
},
{
	"jumpto":"ENAS5564_5.0.0.0",
	"name":"Self-management education & support [T2DM Prev.]"
},
{
	"jumpto":"ENAS5567_1.0.0.0",
	"name":"Self-monitoring of blood glucose [Glycemic Targets]"
},
{
	"jumpto":"ENAS5565_4.13.5.0",
	"name":"Serious mental illness [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5567_4.4.0.0",
	"name":"Setting and Modifying A1C Goals [Glycemic Targets]"
},
{
	"jumpto":"ENAS5566_5.2.0.0",
	"name":"Smoking cessation, recommendations [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5566_5.2.0.0",
	"name":"Smoking cessation [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5574_1.9.3.0",
	"name":"Smoking [Child. & Adol.]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Sodium-Glucose Cotransporter 2 Inhibitors, in older adults"
},
{
	"jumpto":"ENAS5566_3.8.0.0",
	"name":"Sodium [Lifestyle Mgmt.]"
},
{
	"jumpto":"ENAS5576_9.1.0.0",
	"name":"Special situations, standards [Diab. Care]"
},
{
	"jumpto":"ENAS5561_1.2.0.0",
	"name":"Standards of care statements"
},
{
	"jumpto":"ENAS5571_3.6.2.0",
	"name":"Statin and Fibrate [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.6.3.0",
	"name":"Statin and Niacin [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.8.0.0",
	"name":"Statins and cognitive function [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.4.1.0",
	"name":"Statins and Ezetimibe [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.4.2.0",
	"name":"Statins and PCSK9 inhibitors [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_3.3.1.0",
	"name":"Statin treatment, recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5576_10.0.0.0",
	"name":"Structured discharge communication [Hospital Care]"
},
{
	"jumpto":"ENAS5575_4.4.2.0",
	"name":"Sulfonylureas [DM in Preg.]"
},
{
	"jumpto":"ENAS5570_3.0.0.0",
	"name":"Surgical treatment for"
},
{
	"jumpto":"ENAS5562_2.3.0.0",
	"name":"System-level improvement strategies [Population Health]"
},
{
	"jumpto":"ENAS5564_1.0.0.0",
	"name":"T2DM prevention, introduction"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Tapentadol [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5564_2.5.0.0",
	"name":"Tech. assist. to deliver lstyle. intervent. [T2DM Prev.]"
},
{
	"jumpto":"interactive_0001780",
	"name":"Testing in asymptomatic adults [tool]"
},
{
	"jumpto":"ENAS5565_4.10.0.0",
	"name":"Testosterone levels [Eval. of Comorbidities]"
},
{
	"jumpto":"ENAS5573_6.0.0.0",
	"name":"Thiazolidinediones, in older adults"
},
{
	"jumpto":"ENAS5574_1.8.2.0",
	"name":"Thyroid Disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Tramadol [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5574_3.0.0.0",
	"name":"Transition from pediatric to adult care [Child. & Adol.]"
},
{
	"jumpto":"ENAS5576_10.0.0.0",
	"name":"Transition from the acute care setting [Hospital Care]"
},
{
	"jumpto":"ENAS5576_5.2.4.0",
	"name":"Transitioning IV to SQ insulin [Diab. Care]"
},
{
	"jumpto":"ENAS5571_4.3.0.0",
	"name":"Treatment considerations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5562_3.1.0.0",
	"name":"Treatment for socila context, recommendations [Population Health]"
},
{
	"jumpto":"ENAS5571_2.3.1.0",
	"name":"Treatment goals, recommendations [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5569_4.4.0.0",
	"name":"Treatment of obesity, medications [Obesity Mgmt.]"
},
{
	"jumpto":"ENAS5571_3.5.0.0",
	"name":"Treatment of other lipoprotein fractions or targets [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5569_2.0.0.0",
	"name":"Treatment options, overweight and obesity"
},
{
	"jumpto":"ENAS5573_7.0.0.0",
	"name":"Treatment recommendations in nursing facilities, older adults in"
},
{
	"jumpto":"ENAS5571_2.4.1.0",
	"name":"Treatment strategies, lifestyle intervention [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5571_2.4.2.1",
	"name":"Treatment strategies, pharmacologic interventions [CVD & Risk Mgmt]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Tricyclic antidepressants [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5574_1.8.1.0",
	"name":"Type 1 diabetes, autoimmune conditions [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.8.3.0",
	"name":"Type 1 diabetes, celiac disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.2.0.0",
	"name":"Type 1 diabetes, diabetes self-mgmt. education & support [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.7.0.0",
	"name":"Type 1 diabetes, glycemic control [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.1.0.0",
	"name":"Type 1 diabetes, introduction [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.6.0.0",
	"name":"Type 1 diabetes, psychosocial issues [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.5.0.0",
	"name":"Type 1 diabetes, school and child care [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_1.8.2.0",
	"name":"Type 1 diabetes, thyroid Disease [Child. & Adol.]"
},
{
	"jumpto":"ENAS5576_5.2.3.0",
	"name":"Type 1 diabetes [Diab. Care]"
},
{
	"jumpto":"ENAS5575_5.3.0.0",
	"name":"Type 1 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5570_3.0.0.0",
	"name":"type 1 diabetes [Glycemic Tx]"
},
{
	"jumpto":"ENAS5574_2.3.0.0",
	"name":"Type 2 diabetes, diagnostic challenges [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.1.0.0",
	"name":"Type 2 diabetes, introduction [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.4.1.0",
	"name":"Type 2 diabetes, lifestyle management [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.4.1.0",
	"name":"Type 2 diabetes, management [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.4.1.0",
	"name":"Type 2 diabetes, pharmacologic management [Child. & Adol.]"
},
{
	"jumpto":"ENAS5574_2.1.0.0",
	"name":"Type 2 diabetes, screening and diagnosis [Child. & Adol.]"
},
{
	"jumpto":"ENAS5575_5.4.0.0",
	"name":"Type 2 diabetes [DM in Preg.]"
},
{
	"jumpto":"ENAS5572_3.3.2.0",
	"name":"Venlafaxine [Microvasc. Compli.]"
},
{
	"jumpto":"ENAS5566_3.4.0.0",
	"name":"Weight management [Lifestyle Mgmt.]"
}
]